Frontiers in Medicine · Nov 11, 2026

Connecting The Dots: How Obesity And Atherosclerotic Risk Factors Shape IL-1β And Adiponectin Profiles

By Rebeca Cuadra-San Miguel, Cristina Lugones-Sanchez, Luis Garcia-Ortiz et al.

Introduction: Obesity and dyslipidaemia are key risk factors for atherosclerosis and cardiovascular disease. Adipose tissue acts as an endocrine organ, releasing cytokines that influence inflammation. This study examined how obesity, dyslipidaemia, and subclinical atherosclerosis affect circulating inflammatory markers. Methods: Plasma levels of interleukin-1β (IL-1β) and adiponectin were measured in 176 adults recruited from primary care. Participants were categorized by obesity severity, lipid profile, and arterial stiffness parameters. Results: Higher IL-1β levels were found in individuals with abnormal waist-to-hip ratios (WHR), body fat percentage (in men) and elevated triglyceride/HDL cholesterol ratios. Adiponectin levels were significantly lower in those with increased abdominal adiposity (via body adiposity index and WHR). Body mass index did not correlate well with inflammatory profiles, while measures of abdominal fat provided more meaningful associations. While stratification by body mass index did not reveal statistically significant differences in plasma cytokine levels in this cohort, indices of abdominal adiposity (waist-to-hip ratio and body adiposity index) were associated with specific alterations in IL-1β and adiponectin profiles in subgroup comparisons. No significant relationships were found between IL-1β and arterial stiffness indices. However, pulse wave velocity demonstrated a statistically significant independent negative association with log adiponectin Conclusions: Abdominal obesity, dyslipidaemia and arterial stiffness are linked to specific alterations in circulating IL-1β and adiponectin profiles. These findings highlight the potential relevance of incorporating abdominal adiposity measurements alongside standard BMI assessment when evaluating vascular inflammation, supporting further research into the temporal link between metabolic dysfunction, low-grade inflammation, and structural arterial changes.

The paperJournal siteBiomarkers

AgingResearch.News